HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
127,472,754
Share change
+281,086
Total reported value
$2,260,145,336
Put/Call ratio
40%
Price per share
$17.73
Number of holders
218
Value change
+$7,244,846
Number of buys
114
Number of sells
93

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
12%
14,228,129
$220,678,000 30 Sep 2019
13F
BlackRock Finance, Inc.
13F
Company
11%
13,004,538
$201,701,000 30 Sep 2019
13F
Third Security, LLC
13F
Company
7.8%
9,706,087
$150,541,000 30 Sep 2019
13F
Bellevue Group AG
13F
Company
6.5%
8,014,356
$124,303,000 30 Sep 2019
13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
4.4%
5,415,995
$84,002,000 30 Sep 2019
13F
Invesco Ltd.
13F
Company
4.3%
5,266,794
$81,688,000 30 Sep 2019
13F
JPMORGAN CHASE & CO
13F
Company
4.1%
5,024,697
$77,933,000 30 Sep 2019
13F
STATE STREET CORP
13F
Company
3.6%
4,510,918
$69,964,000 30 Sep 2019
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
3.6%
4,462,433
$69,212,000 30 Sep 2019
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
3.1%
3,865,719
$59,957,000 30 Sep 2019
13F
Artisan Partners Limited Partnership
13F
Company
2.6%
3,160,743
$49,023,000 30 Sep 2019
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
2.4%
3,017,306
$46,798,000 30 Sep 2019
13F
SNYDER CAPITAL MANAGEMENT L P
13F
Company
2.2%
2,721,858
$42,216,000 30 Sep 2019
13F
FMR LLC
13F
Company
2.1%
2,561,426
$39,728,000 30 Sep 2019
13F
NORTHERN TRUST CORP
13F
Company
1.6%
2,005,625
$31,108,000 30 Sep 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.5%
1,824,500
$28,297,000 30 Sep 2019
13F
NORGES BANK
13F
Company
1.5%
1,810,203
$28,076,000 30 Sep 2019
13F
First Light Asset Management, LLC
13F
Company
1.4%
1,682,745
$26,099,000 30 Sep 2019
13F
First Eagle Investment Management, LLC
13F
Company
1.3%
1,637,475
$25,397,000 30 Sep 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.3%
1,603,701
$24,873,000 30 Sep 2019
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
1.2%
1,540,616
$23,894,000 30 Sep 2019
13F
LOOMIS SAYLES & CO L P
13F
Company
1%
1,292,163
$20,041,000 30 Sep 2019
13F
Nuveen Asset Management, LLC
13F
Company
1%
1,265,341
$19,625,000 30 Sep 2019
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
1%
1,244,666
$19,305,000 30 Sep 2019
13F
Fisher Asset Management, LLC
13F
Company
0.95%
1,169,916
$18,145,000 30 Sep 2019
13F
CARILLON TOWER ADVISERS, INC.
13F
Company
0.85%
1,052,974
$16,332,000 30 Sep 2019
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.83%
1,029,443
$15,967,000 30 Sep 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.79%
972,470
$15,083,000 30 Sep 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.73%
904,946
$14,036,000 30 Sep 2019
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.72%
888,938
$13,787,429 30 Sep 2019
13F
Granite Investment Partners, LLC
13F
Company
0.7%
867,396
$13,453,000 30 Sep 2019
13F
Elk Creek Partners, LLC
13F
Company
0.61%
758,553
$11,765,000 30 Sep 2019
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.61%
750,000
$11,633,000 30 Sep 2019
13F
Man Group plc
13F
Company
0.59%
727,733
$11,287,000 30 Sep 2019
13F
S.c.a. Candriam
13F
Individual
0.52%
647,079
$10,036,000 30 Sep 2019
13F
Bank of New York Mellon Corp
13F
Company
0.52%
643,467
$9,981,000 30 Sep 2019
13F
Sofinnova Investments, Inc.
13F
Company
0.51%
636,167
$9,867,000 30 Sep 2019
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.45%
558,391
$8,661,000 30 Sep 2019
13F
D. E. Shaw & Co., Inc.
13F
Company
0.44%
548,665
$8,510,000 30 Sep 2019
13F
FEDERATED HERMES, INC.
13F
Company
0.43%
532,517
$8,260,000 30 Sep 2019
13F
MORGAN STANLEY
13F
Company
0.43%
528,091
$8,191,000 30 Sep 2019
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.4%
489,002
$7,584,000 30 Sep 2019
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.33%
406,062
$6,299,000 30 Sep 2019
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.3%
375,083
$5,818,000 30 Sep 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.3%
373,064
$5,785,000 30 Sep 2019
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.28%
349,820
$5,426,000 30 Sep 2019
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.27%
338,060
$5,243,000 30 Sep 2019
13F
Sio Capital Management, LLC
13F
Company
0.26%
320,373
$4,969,000 30 Sep 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.25%
315,161
$4,888,000 30 Sep 2019
13F
Lombard Odier Asset Management (Switzerland) SA
13F
Company
0.24%
300,000
$4,653,000 30 Sep 2019
13F

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q4 2019

As of 31 Dec 2019, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 218 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 127,472,754 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Bellevue Group AG, Third Security, LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Artisan Partners Limited Partnership, Invesco Ltd., JPMORGAN CHASE & CO, STATE STREET CORP, and SNYDER CAPITAL MANAGEMENT L P. This page lists 218 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
206
Q4 2019 holders
218
Holder diff
12
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 Value $ Q4 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.